my take on this one is D.
Scientist think that nicotine contains some factor that turns the receptors upside-down, thus resulting in the anti-cancer chemical’s inability to bind with the receptors.
which means that The therapeutic regimen will fail if the binding at the receptor level is abnormal
daagh
Could you provide OA and OE for this question
Scientist think that nicotine contains some factor that turns the receptors upside-down, thus resulting in the anti-cancer chemical’s inability to bind with the receptors.
which means that The therapeutic regimen will fail if the binding at the receptor level is abnormal
daagh
Could you provide OA and OE for this question






